WuXi XDC Cayman Inc

WuXi XDC’s 2025 profit alert and 60% premium BioDlink bid signal double‑digit growth, high‑margin ADC CDMO leadership, and a promising merger‑synergy outlook.

WuXi XDC Cayman Inc.’s stock price surges to new highs on the Hong Kong Stock Exchange after the company issues a positive profit alert, forecasting significant growth in its interim net profit.

WuXi XDC Cayman Inc. has announced key developments ahead of its upcoming Annual General Meeting, including director elections, share issuance proposals, and a change in AGM date, as the company prepares to drive future growth in the bioconjugate market.